Table 3.
Clinico-pathological parameters of the PDAC study cohort stratified by the percentage of monocytes in low (n = 15; ≤5%) and high (n = 43; >5%).
| Percentage of Monocytes | Low | High | p-Value | |
|---|---|---|---|---|
| Number | 15 | 43 | ||
| Mean Age (in years [range]) | 69 (51–90) | 64 (45–86) | 0.7068 | |
| Sex | Male (%) | 6 (40) | 25 (58) | 0.23 |
| Female (%) | 9 (60) | 18 (42) | ||
| Tumor size pT | 1 (%) | 3 (20) | 4 (9) | 0.40 |
| 2 (%) | 2 (13) | 13 (30) | ||
| 3 (%) | 5 (33) | 9 (21) | ||
| 4 (%) | 0 (0) | 3 (7) | ||
| Unknown/Inoperable (%) | 5 (33) | 14 (33) | ||
| pN-category | pN0 (%) | 6 (40) | 8 (19) | 0.18 |
| pN+ (%) | 4 (27) | 21 (49) | ||
| Unknown/Inoperable (%) | 5 (33) | 14 (32) | ||
| Perineural invasion | Pn0 (%) | 8 (53) | 7 (16) | <0.01 |
| Pn+ (%) | 2 (13) | 22 (51) | ||
| Unknown/Inoperable (%) | 5 (33) | 14 (33) | ||
| R-status | R0 (%) | 9 (60) | 30 (70) | 0.49 |
| R+ (%) | 6 (40) | 13 (30) | ||
| Grading | G2 (%) | 8 (53) | 5 (12) | <0.01 |
| G3 (%) | 5 (33) | 27 (63) | ||
| Unknown (%) | 2 (13) | 11 (26) | ||
| Distant Metastasis | No (%) | 9 (60) | 32 (74) | 0.29 |
| Yes (%) | 6 (40) | 11 (26) | ||
| UICC stage | I (%) | 2 (13) | 5 (12) | 0.75 |
| II (%) | 4 (27) | 18 (42) | ||
| III (%) | 1 (7) | 5 (12) | ||
| IV (%) | 6 (40) | 11 (26) | ||
| Unknown/Inoperable (%) | 2 (13) | 4 (9) | ||
| Neoadjuvant treatment | No (%) | 10 (67) | 35 (81) | 0.24 |
| Yes (%) | 5 (33) | 8 (19) |